Nonadherence with inhaled preventer therapy in severe asthmatic patients on long-term omalizumab

Eur Respir J. 2018 Aug 16;52(2):1801025. doi: 10.1183/13993003.01025-2018. Print 2018 Aug.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Asthmatic Agents*
  • Asthma*
  • Biological Products*
  • Forced Expiratory Volume / drug effects
  • Humans
  • Omalizumab

Substances

  • Anti-Asthmatic Agents
  • Biological Products
  • Omalizumab